Related Experiment Video
Updated: Aug 14, 2026
09:03
The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
Autoimmune liver diseases
1Department of Gastroenterology, Scripp's Clinic and Research Foundation, La Jolla, California, USA.
Clinics in Laboratory Medicine
|October 8, 1997
Summary
Autoantibodies are key diagnostic markers for autoimmune liver diseases (AiLD), though their exact cause remains unclear. Cell-mediated immunity also plays a crucial role in liver injury in these conditions.
Area of Science:
- Immunology
- Hepatology
- Autoimmunity
Background:
- Autoimmune liver diseases (AiLD) are characterized by autoantibodies and humoral immune abnormalities.
- The precise etiology and pathogenesis of AiLD are not fully understood.
- Cell-mediated immune mechanisms are increasingly recognized as critical contributors to tissue injury in AiLD.
Purpose of the Study:
- To review the role of autoantibodies as diagnostic markers in AiLD.
- To discuss the diagnostic utility of specific autoantibodies like AMA, ANA, SMA, and LKM.
- To highlight the importance of standardized testing methods for autoantibodies in AiLD diagnosis.
Main Methods:
- Review of literature on autoantibody detection in autoimmune liver diseases.
- Discussion of immunofluorescence assays (IIFM) for ANA, SMA, and LKM detection.
- Mention of enzyme-linked immunosorbent assays (ELISA) for AMA (anti-M2) quantification.
Main Results:
- Antimitochondrial antibodies (AMA) are the most sensitive and specific marker for primary biliary cholangitis (PBC).
- Antinuclear antibodies (ANA), smooth muscle antibodies (SMA), and liver kidney microsomal antibodies (LKM) characterize autoimmune hepatitis (AiH).
- IIFMs using Hep-2 cells and rodent tissues are common methods for detecting these autoantibodies.
Conclusions:
- Serum autoantibodies are valuable diagnostic markers for AiLD.
- Standardization of autoantibody testing through methods like ELISA will improve diagnostic accuracy.
- Understanding both humoral and cell-mediated immunity is essential for managing AiLD.
Related Concept Videos
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:25Chronic Pancreatitis I: Introduction
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...